Skip to main content

Larry Ellison Donates $200 Million for Cancer Research

The Oracle cofounder’s gift will fund a new institute at the University of Southern California.

Written byTanya Lewis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

Larry EllisonFLICKR, ORACLE PRLarry Ellison, the billionaire cofounder of software giant Oracle, has donated $200 million to the University of Southern California (USC) to fund the creation of a new institute for cancer research, the university announced yesterday (May 11). The Lawrence J. Ellison Institute for Transformative Medicine will be led by USC Professor of Medicine and Engineering David Agus, and will combine diverse fields of research.

“This investment by Larry Ellison in USC is as inspirational as it is momentous, and it will serve as a dynamic force for change in how we approach cancer treatment and prevention,” USC President C. L. Max Nikias said in the statement.

The money will mostly be used to fund a new building in west Los Angeles—set to open in around 2.5 years—and to support research and artist residency programs, Agus told Bloomberg Technology. “There will be clinics, engineering labs, think tanks, and kids will be able to go on tours all day because we need to excite the next generation,” he said.

Ellison, who is worth nearly $50 billion, has previously given money to aging research, animal welfare, and polio eradication efforts, The Wall ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays